Alan Krasner's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 1,687 Common Stock done at an average price of $17.1 . Disclosure was reported to the exchange on March 16, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 16 Mar 2023 | 1,687 | 42,301 (0%) | 0% | 17.1 | 28,881 | Common Stock | |
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 01 Mar 2023 | 91,000 | 91,000 | - | - | Common Stock (right to buy) | ||
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 01 Mar 2023 | 19,500 | 43,988 (0%) | 0% | 0 | Common Stock | ||
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 31 Dec 2022 | 1,215 | 23,776 (0%) | 0% | 11.0 | 13,389 | Common Stock | |
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 31 Dec 2022 | 712 | 24,488 (0%) | 0% | 11.0 | 7,846 | Common Stock | |
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 28 Feb 2022 | 66,500 | 66,500 | - | - | Common Stock (right to buy) | ||
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 28 Feb 2022 | 14,250 | 22,561 (0%) | 0% | 0 | Common Stock | ||
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 19 Jan 2022 | 6,700 | 8,311 (0%) | 0% | 21.2 | 142,080 | Common Stock | |
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 19 Jan 2022 | 6,700 | 160,473 | - | - | Non-qualified stock option (Right to Buy) | ||
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 19 Jan 2022 | 6,700 | 15,011 (0%) | 0% | 12.0 | 80,467 | Common Stock | |
Crinetics Pharmaceuticals Inc | Alan Krasner | Chief Medical Officer | 26 Feb 2021 | 125,000 | 125,000 | - | - | Stock Option (right to buy) |